Karyopharm Therapeutics
KPTI
KPTI
47 hedge funds and large institutions have $13.7M invested in Karyopharm Therapeutics in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 30 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-40
Holders Change %
-45.98%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
30
Closed
42
Calls
$581K
Puts
$95K
Net Calls
+$486K
Net Calls Change
+$337K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$570K |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$523K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$457K |
| 4 |
EP
Eversept Partners
New York
|
+$441K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$314K |
